What Makes Ginkgo biloba Live for Thousand Years

Gingko trees lives for thousands years by evolving compensatory mechanisms to maintain a balance between growth and ageing.

Ginkgo biloba, a deciduous gymnosperm tree native to China is known commonly as health supplement and as herbal medicine.

It is also known for living a very long life.

Some of the Gingko trees in China and Japan are more than thousand year old. Ginkgo is said to be a living fossil. It is the only living species that can live for more than 1000 years defying ageing, the most universal property of living organisms. Hence, Gingko is sometimes referred to be near immortal.

The science behind longevity of such ancient trees has been of immense interest to the longevity research professionals. One such group, after investigating age-related changes in the vascular cambium from 15 to 667 year old Ginkgo biloba trees, has published their findings recently on January 13, 2020 in PNAS.

In plants, reduction in activity of meristem (the undifferentiated cells that give rise to tissue) is associated with ageing. In larger plants like Gingko, the activity of meristem in vascular cambium (main growth tissue in the stems) is the focus.

This group studied the variation in properties of vascular cambium in mature and old Gingko trees at the cytological, physiological, and molecular levels. They found that the old trees had evolved compensatory mechanisms to maintain a balance between growth and ageing.

The mechanisms involved continued cell division in the vascular cambium, high expression of resistance-associated genes, and continued synthetic capacity of preformed protective secondary metabolites. This study gives an insight into how such old trees continue growing through these mechanisms.

***

Source(s)

Wang Li et al., 2020. Multifeature analyses of vascular cambial cells reveal longevity mechanisms in old Ginkgo biloba trees. PNAS first published January 13, 2020. DOI: https://doi.org/10.1073/pnas.1916548117

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Carbon Capture Based on Crystallization of Bicarbonate-water Clusters

A new carbon capture method to control global warming...

Molnupiravir: A Game Changing Oral Pill for Treatment of COVID-19

Molnupiravir, a nucleoside analog of cytidine, a drug that has shown...

Potential Use for New GABA-Targeting Drugs in Alcohol Use Disorder

Use of GABAB (GABA type B) agonist, ADX71441, in preclinical...

Delivering Oral Dose of Insulin to Patients of Type 1 Diabetes: Trial Successful in Pigs

A new pill has been designed which delivers insulin...

COVID-19 Situation across Europe is Very Serious

COVID-19 situation across Europe and central Asia is very...

20C-US: New Coronavirus Variant in the USA

Researchers at Southern Illinois University have reported a new variant of SARS...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...